Ürək-damar cərrahiyyəsi

  Ю.В.Белов. «Руководство по сердечно-сосудистой хирургии с атласом оперативной техники» 2000 г., 148 с.

  Ю.В.Белов. «Руководство по сердечно-сосудистой хирургии с атласом оперативной техники» 2000 г., 148 с.

  Ю.В.Белов. «Руководство по сердечно-сосудистой хирургии с атласом оперативной техники» 2000 г., 148 с.

  Karchmer AW. Infective endocarditis. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 7th ed. WB Saunders Co; 2005. 1633-1658. Karchmer AW. Infective endocarditis. Harrison’s Principles of Internal Medicine. 16th ed. McGraw-Hill; 2005. 731-40. http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/infectious-disease/infective-endocarditis/

  Hirsh J, Raschke R. Heparin and low-molecular-weight heparin: the Seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126:188S–203S. [PubMed] Picker SM, Gathof BS. Pathophysiology, epidemiology, diagnosis and treatment of heparin-induced thrombocytopenia (HIT) Eur J Med Res. 2004;9:180–185. [PubMed] Wittkowsky AK. Warfarin and other coumarin derivatives: pharmacokinetics, pharmacodynamics, and drug interactions. Semin Vasc Med. 2003;3:221–230. [PubMed] Wittkowsky AK. New oral anticoagulants: a practical guide for clinicians. J Thromb Thrombolysis. 2010;29:182–191.

  Callum JL, Lin Y, Pinkerton PH, Karkouti K, Pendergrast JM, Robitaile N et al. Chapter 5, Transfusion Reactions. Bloody Easy 3: Blood Transfusions, Blood Alternatives and Transfusion Reactions: A Guide to Transfusion Medicine, 3rd edition. Canada: Ontario Regional Blood Coordinating Network, 2011. Available from: http://transfusionontario.org/en/documents/?cat=bloody_easy, Fung MK (ed). Non-infectious complications of blood transfusion. Chapter 27, AABB Technical Manual, 18th edition. AABB, Bethesda, 2014. - See more at: https://www.transfusion.com.au/adverse_transfusion_reactions/acute_haemolytic_reaction#sthash.Hwtx1zap.dpuf

  Crosson JT: Massive transfusion. Clin Lab Med 1996; 16 :873– 882 Lapointe LA, Von Rueden KT: Coagulopathies in trauma patients. AACN Clin Issues 2002; 13 :192–203 Hardy JF, De Moerloose P, Samama M: Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth 2004; 51 :293–310

  Tendera M, Wojakowski W. Role of antiplatelet drugs in the prevention of cardiovascular events. Thromb Res 2003;110:355-9.Hall R, Mazer CD. Antiplatelet drugs: a review of their pharmacology and management in the perioperative period. Anesth Analg 2011;112:292-318.

  http://jamanetwork.com/journals/jama/fullarticle/2569055., https://www.blood.gov.au/system/files/documents/companion-24-pbm-guidelines.pdf

  Ədəbiyyat verilməyib

  Hirsh J, Raschke R. Heparin and low-molecular-weight heparin: the Seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126:188S–203S. [PubMed] Picker SM, Gathof BS. Pathophysiology, epidemiology, diagnosis and treatment of heparin-induced thrombocytopenia (HIT) Eur J Med Res. 2004;9:180–185. [PubMed] Wittkowsky AK. Warfarin and other coumarin derivatives: pharmacokinetics, pharmacodynamics, and drug interactions. Semin Vasc Med. 2003;3:221–230. [PubMed] Wittkowsky AK. New oral anticoagulants: a practical guide for clinicians. J Thromb Thrombolysis. 2010;29:182–191.

  Tintinalli JE, Kelen GD, Stapczynski JS. Emergency Medicine: A Comprehensive Study Guide. 5th ed. New York, NY: McGraw Hill; 2000.Ganz LI. Approach to the Patient with Supraventricular Tachycardia. Ganz LI, ed. Management of Cardiac Arrhythmias. Totowa, NJ: Humana; 2002. 29-49.Whinnett ZI, Sohaib SM, Davies DW. Diagnosis and management of supraventricular tachycardia. BMJ. 2012. 345:e7769.

  Tintinalli JE, Kelen GD, Stapczynski JS. Emergency Medicine: A Comprehensive Study Guide. 5th ed. New York, NY: McGraw Hill; 2000.Ganz LI. Approach to the Patient with Supraventricular Tachycardia. Ganz LI, ed. Management of Cardiac Arrhythmias. Totowa, NJ: Humana; 2002. 29-49.Whinnett ZI, Sohaib SM, Davies DW. Diagnosis and management of supraventricular tachycardia. BMJ. 2012. 345:e7769.

  R. Adams. Cases of Diseases of the Heart, Accompanied with Pathological Observations. Dublin Hospital Reports, 1827, 4: 353–453.W. Stokes. Observations on some cases of permanently slow pulse. Dublin Quarterly Journal of Medical Science, 1846, 2: 73–85. http://patient.info/doctor/Stokes-Adams-Attacks., Katz, Jason; Patel, Chetan (2006). Parkland Manual of Inpatient Medicine. Dallas, TX: FA Davis. p. 903.

  Tapson VF. Acute pulmonary embolism. N Engl J Med. 2008 Mar 6. 358(10):1037-52.Clagett GP, Sobel M, Jackson MR, Lip GY, Tangelder M, Verhaeghe R. Antithrombotic therapy in peripheral arterial occlusive disease: The Seventh ACCPConference on Antithrombotic and Thrombolytic Therapy. Chest.2004;126(Suppl 3):609S–26. Menke J, Lüthje L, Kastrup A, Larsen J. Thromboembolism in atrial fibrillation. Am J Cardiol. 2012;105:502–10.

  Lick CJ, Aufderheide TP, Niskanen RA, et al. Take Heart America: A comprehensive, community-wide, systems-based approach to the treatment of cardiac arrest. Crit Care Med. 2011 Jan. 39(1):26-33[Guideline] American Heart Association. Part 8: Adult Advanced Cardiovascular Life Support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010 Nov 2. 122(18 Suppl 3):S729-67. Nolan JP, De Latorre FJ, Steen PA, et al. Advanced life support drugs: do they really work?.Curr Opin Crit Care. 2002 Jun. 8(3):212-8.

  https://www.ncbi.nlm.nih.gov/pubmed/3221309

  West J Emerg Med. 2008 Jan; 9(1): 28–39. Wide Complex Tachycardias: Understanding this Complex Condition: Part 1 – Epidemiology and Electrophysiology. Gus M. Garmel, MD

  [Guideline] Russo AM, Stainback RF, Bailey SR, et al. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovas...J Am Coll Cardiol. 2013 Mar 26. 61(12):1318-68.Rassi A Jr, Rassi A, Rassi SG. Predictors of mortality in chronic Chagas disease: a systematic review of observational studies.Circulation. 2007 Mar 6. 115(9):1101-8.Brugada J, Brugada R, Brugada P. Channelopathies: a new category of diseases causing sudden death. Herz. 2007 May. 32(3):185-91. [Guideline] Russo AM, Stainback RF, Bailey SR, et al. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovas...J Am Coll Cardiol. 2013 Mar 26. 61(12):1318-68.

  http://circ.ahajournals.org/content/102/suppl_1/I-112.full